Skip to main content
. 2014 Mar 4;55(3):1299–1309. doi: 10.1167/iovs.13-13122

Table 1.

Patient Demographics

Patient ID
Diagnosis
Age, y
Sex
Eye
Race/Ethnicity
Ophthalmic Treatment History
RR_0067 CRVO 51 M OS White Anti-VEGF ×1
RR_0072 DR 52 M OD Hispanic PRP
RR_0084 DR 48 M OD African-American No treatment
RR_0086 DR 46 F OD Hispanic PRP, anti-VEGF ×3
RR_0095 HTN 47 M OD Hispanic No treatment
RR_0099 BRVO 55 F OS White No treatment
RR_0120 DR 68 M OS Hispanic PRP
RR_0129 BRVO 54 F OS African-American No treatment
RR_0148 DR 53 F OS Hispanic Focal laser
RR_0149 CRVO 44 M OD White Anti-VEGF ×2
RR_0151 CRVO 64 F OS Hispanic Anti-VEGF ×8
RR_0167 DR 49 F OU White No treatment
RR_0182 CRVO 55 M OD White Anti-VEGF ×6

PRP, pan-retinal photocoagulation.

HHS Vulnerability Disclosure